The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Clinical Role of FDG PET in Evaluation of Cancer Patients
Abstract
Positron emission tomography (PET) is a diagnostic imaging technique that allows identification of biochemical and physiologic alterations in tumors. Use of PET performed with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) significantly improves the accuracy of tumor imaging. In terms of oncologic applications, FDG PET has already gained widespread acceptance in the initial staging of cancer, management of recurrent cancer, and monitoring the response to therapy. With conventional imaging modalities, size criteria are used to distinguish between benign and malignant disease in lymph nodes; conversely, FDG PET is based on identification of fundamental aspects of tumor metabolism. FDG uptake in tumors is proportional to the metabolic rate of viable tumor cells, which have an increased demand for glucose. The high sensitivity and high negative predictive value of FDG PET in most malignant tumors enable this technique to play an even greater role in tumor management at initial staging and follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Gould, M. K., Maclean, C. C., Kuschner, W. G., Rydzak, C. E., & Owens, D. K. (2001) · JAMA · doi:10.1001/jama.285.7.914 · Cited by 1,094
Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants
Shreve, P. D., Anzai, Y., & Wahl, R. L. (1999) · RadioGraphics · doi:10.1148/radiographics.19.1.g99ja0761 · Cited by 827
Jerusalem, G., Beguin, Y., Fassotte, M. F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999) · Blood · doi:10.1182/blood.v94.2.429 · Cited by 565
Avril, N., Rosé, C. A., Schelling, M., Dose, J., Kuhn, W., Bense, S., Weber, W., Ziegler, S., Graeff, H., & Schwaiger, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3495 · Cited by 557
Prospective investigation of positron emission tomography in lung nodules.
Lowe, V. J., Fletcher, J. W., Gobar, L., Lawson, M., Kirchner, P., Valk, P., Karis, J., Hubner, K., Delbeke, D., Heiberg, E. V., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1075 · Cited by 552
Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Werner, M., Dose, J., Jänicke, F., Graeff, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1689 · Cited by 522
Adams, S., Baum, R. P., Stuckensen, T., Bitter, K., & Hör, G. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050293 · Cited by 487
Local recurrence following ‘curative’ surgery for large bowel cancer: I. The overall picture
Phillips, R. K. S., Hittinger, R., Blesovsky, L., Fry, J. S., & Fielding, L. P. (1984) · Journal of British Surgery · doi:10.1002/bjs.1800710104 · Cited by 480
Cited by
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Tuberculosis: A Radiologic Review
Burrill, J., Williams, C. J., Bain, G., Conder, G., Hine, A. L., & Misra, R. R. (2007) · RadioGraphics · doi:10.1148/rg.275065176 · Cited by 604
A review on segmentation of positron emission tomography images
Foster, B., Bagci, U., Mansoor, A., Xu, Z., & Mollura, D. J. (2014) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2014.04.014 · Cited by 370
False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases
Chang, J. M., Lee, H. J., Goo, J. M., Lee, H.-Y., Lee, J. J., Chung, J.-K., & Im, J.-G. (2006) · Korean Journal of Radiology · doi:10.3348/kjr.2006.7.1.57 · Cited by 357
Ben-Cohen, A., Klang, E., Raskin, S. P., Soffer, S., Ben-Haim, S., Konen, E., Amitai, M. M., & Greenspan, H. (2019) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2018.11.013 · Cited by 231
100 years of the Warburg effect: A cancer metabolism endeavor
Fendt, S.-M. (2024) · Cell · doi:10.1016/j.cell.2024.06.026 · Cited by 223
(2004) · PubMed · Cited by 211
FDG PET/CT-based response assessment in malignancies
Parihar, A. S., Dehdashti, F., & Wahl, R. L. (2023) · RadioGraphics · doi:10.1148/rg.220122 · Cited by 53
“…site for histopathologic sampling, initial staging of a known malignancy to determine the disease extent and disease activity for treatment planning, monitoring response to treatment, and surveillance in cases of high-risk malignancies and to evaluate suspected disease recurrence (12–17).”
Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT
Pencharz, D., Nathan, M., & Wagner, T. L. (2018) · The British Journal of Radiology · doi:10.1259/bjr.20170774 · Cited by 42
Metadata
- Authors
- Kostakoglu, L., Agress, H., & Goldsmith, S. J.
- Venue
- RadioGraphics
- Published
- 2003-03
- Volume
- 23
- Issue
- 2
- Pages
- 315-340
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2022380377
- Cited by
- 402
- References
- 87
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.